• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体介导的针对原型猴免疫缺陷病毒的保护作用的分子机制研究。

Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.

机构信息

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.

出版信息

Nat Commun. 2022 Sep 6;13(1):5236. doi: 10.1038/s41467-022-32783-2.

DOI:10.1038/s41467-022-32783-2
PMID:36068229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9446601/
Abstract

SIVmac239 infection of macaques is a favored model of human HIV infection. However, the SIVmac239 envelope (Env) trimer structure, glycan occupancy, and the targets and ability of neutralizing antibodies (nAbs) to protect against SIVmac239 remain unknown. Here, we report the isolation of SIVmac239 nAbs that recognize a glycan hole and the V1/V4 loop. A high-resolution structure of a SIVmac239 Env trimer-nAb complex shows many similarities to HIV and SIVcpz Envs, but with distinct V4 features and an extended V1 loop. Moreover, SIVmac239 Env has a higher glycan shield density than HIV Env that may contribute to poor or delayed nAb responses in SIVmac239-infected macaques. Passive transfer of a nAb protects macaques from repeated intravenous SIVmac239 challenge at serum titers comparable to those described for protection of humans against HIV infection. Our results provide structural insights for vaccine design and shed light on antibody-mediated protection in the SIV model.

摘要

SIVmac239 感染恒河猴是人类 HIV 感染的首选模型。然而,SIVmac239 的包膜(Env)三聚体结构、聚糖占有率,以及中和抗体(nAbs)的靶标和保护能力针对 SIVmac239 仍不清楚。在这里,我们报告了分离 SIVmac239 nAbs 的研究,这些 nAbs 可识别聚糖孔和 V1/V4 环。SIVmac239 Env 三聚体-nAb 复合物的高分辨率结构与 HIV 和 SIVcpz Envs 非常相似,但 V4 特征和延伸的 V1 环不同。此外,SIVmac239 Env 的聚糖屏蔽密度高于 HIV Env,这可能导致 SIVmac239 感染的恒河猴中 nAb 反应不佳或延迟。nAb 的被动转移可保护猕猴免受重复静脉内 SIVmac239 攻击,血清滴度与描述的可预防人类 HIV 感染的水平相当。我们的研究结果为疫苗设计提供了结构见解,并阐明了 SIV 模型中的抗体介导的保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/36a2fd396558/41467_2022_32783_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/83ac71293a6f/41467_2022_32783_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/6a3c81ac0f46/41467_2022_32783_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/8c7cd942d706/41467_2022_32783_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/6766eb2f4f0d/41467_2022_32783_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/248547a4af60/41467_2022_32783_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/36a2fd396558/41467_2022_32783_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/83ac71293a6f/41467_2022_32783_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/6a3c81ac0f46/41467_2022_32783_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/8c7cd942d706/41467_2022_32783_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/6766eb2f4f0d/41467_2022_32783_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/248547a4af60/41467_2022_32783_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4da/9448735/36a2fd396558/41467_2022_32783_Fig6_HTML.jpg

相似文献

1
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.抗体介导的针对原型猴免疫缺陷病毒的保护作用的分子机制研究。
Nat Commun. 2022 Sep 6;13(1):5236. doi: 10.1038/s41467-022-32783-2.
2
Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.尽管在接种SIV毒株mac239的恒河猴中产生了有效的自体中和抗体反应,但SIV毒株smE660仍能突破其免疫防线。
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10780-5. doi: 10.1073/pnas.1509731112. Epub 2015 Aug 10.
3
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.直肠获取猴免疫缺陷病毒(SIV),尽管针对整个 SIV 蛋白组产生了疫苗诱导的免疫反应,但仍会感染 SIVmac239。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00979-20.
4
Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.急性 SIV 感染中被动非中和性抗体免疫对恒河猴病毒血症控制的影响有限。
PLoS One. 2013 Sep 9;8(9):e73453. doi: 10.1371/journal.pone.0073453. eCollection 2013.
5
Rhesus Macaques Vaccinated with , , and Manifest Early Control of SIVmac239 Replication.恒河猴接种 、 、 和 后,早期控制 SIVmac239 复制。
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00690-18. Print 2018 Aug 15.
6
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields.分离并鉴定可中和 SIVmac239 病毒的全中和抗体揭示 SIV 和 HIV 聚糖盾牌具有相似功能。
Immunity. 2019 Oct 15;51(4):724-734.e4. doi: 10.1016/j.immuni.2019.09.007. Epub 2019 Oct 2.
7
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.BG505 艾滋病毒 1 型包膜中的 C3/465 聚糖孔簇是主要的中和靶点,可预防粘膜性 SHIV 感染。
PLoS Pathog. 2021 Feb 8;17(2):e1009257. doi: 10.1371/journal.ppat.1009257. eCollection 2021 Feb.
8
Post-infection immunodeficiency virus control by neutralizing antibodies.感染后通过中和抗体控制艾滋病毒。
PLoS One. 2007 Jun 20;2(6):e540. doi: 10.1371/journal.pone.0000540.
9
Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.在评估表达SIVmac239包膜的多模式疫苗在恒河猴中引发的中和抗体广度时,多样化的猿猴免疫缺陷病毒SIVsm包膜组合的表征与应用
J Virol. 2015 Aug;89(16):8130-51. doi: 10.1128/JVI.01221-14. Epub 2015 May 27.
10
Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.急性期被动中和抗体免疫在猿猴免疫缺陷病毒控制中的双相CD8 + T细胞防御作用
J Virol. 2016 Jun 24;90(14):6276-6290. doi: 10.1128/JVI.00557-16. Print 2016 Jul 15.

引用本文的文献

1
Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques.将恒河猴巨细胞病毒/猴免疫缺陷病毒疫苗与一种中和抗体联合使用,以保护恒河猴免受猴免疫缺陷病毒攻击。
Front Microbiol. 2025 Jun 2;16:1592647. doi: 10.3389/fmicb.2025.1592647. eCollection 2025.
2
Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells.强效广谱中和抗体介导有效的抗体依赖的吞噬作用清除 HIV 感染细胞。
PLoS Pathog. 2024 Oct 28;20(10):e1012665. doi: 10.1371/journal.ppat.1012665. eCollection 2024 Oct.
3
Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy.

本文引用的文献

1
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization.免疫接种诱导的抗体驱动 HIV 包膜糖蛋白三聚体免疫原的解体。
Sci Adv. 2021 Jul 28;7(31). doi: 10.1126/sciadv.abh2791. Print 2021 Jul.
2
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.两项预防 HIV-1 感染的中和抗体随机临床试验
N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.
3
3D variability analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM.
腺相关病毒介导的Env特异性抗体递送可防止在停止抗逆转录病毒治疗后SIV反弹。
bioRxiv. 2024 Jun 3:2024.05.30.593694. doi: 10.1101/2024.05.30.593694.
4
Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge.V2 特异性抗体的有效抗体依赖细胞细胞毒性不足以保护猕猴免受 SIV 挑战。
PLoS Pathog. 2024 Jan 22;20(1):e1011819. doi: 10.1371/journal.ppat.1011819. eCollection 2024 Jan.
5
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection.CD8+ 细胞和小病毒库有助于在感染后两周开始接受 ART 的 M3+毛里求斯食蟹猴模型中控制 SIV 复制。
PLoS Pathog. 2023 Sep 25;19(9):e1011676. doi: 10.1371/journal.ppat.1011676. eCollection 2023 Sep.
3D 变异性分析:从单颗粒冷冻电镜中解析连续的柔韧性和离散的异质性。
J Struct Biol. 2021 Jun;213(2):107702. doi: 10.1016/j.jsb.2021.107702. Epub 2021 Feb 11.
4
Quantification of the Resilience and Vulnerability of HIV-1 Native Glycan Shield at Atomistic Detail.原子水平上HIV-1天然聚糖屏蔽的弹性和脆弱性的量化
iScience. 2020 Nov 20;23(12):101836. doi: 10.1016/j.isci.2020.101836. eCollection 2020 Dec 18.
5
Visualization of the HIV-1 Env glycan shield across scales.HIV-1 包膜糖蛋白盾的多尺度可视化。
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28014-28025. doi: 10.1073/pnas.2000260117. Epub 2020 Oct 22.
6
Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques.描绘中和抗体表位特异性与免疫和感染恒河猴 HIV 包膜三聚体的关系。
Cell Rep. 2020 Sep 8;32(10):108122. doi: 10.1016/j.celrep.2020.108122.
7
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.UCSF ChimeraX:面向研究人员、教育工作者和开发者的结构可视化工具。
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.
8
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.T 细胞诱导疫苗可持久预防黏膜 SHIV 感染,即使中和抗体滴度较低。
Nat Med. 2020 Jun;26(6):932-940. doi: 10.1038/s41591-020-0858-8. Epub 2020 May 11.
9
Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies.诱导瞬时病毒复制有助于SIV特异性单克隆抗体的抗原非依赖性分离。
Mol Ther Methods Clin Dev. 2020 Feb 13;16:225-237. doi: 10.1016/j.omtm.2020.01.010. eCollection 2020 Mar 13.
10
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields.分离并鉴定可中和 SIVmac239 病毒的全中和抗体揭示 SIV 和 HIV 聚糖盾牌具有相似功能。
Immunity. 2019 Oct 15;51(4):724-734.e4. doi: 10.1016/j.immuni.2019.09.007. Epub 2019 Oct 2.